Month: September 2023

NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) — Eyenovia, Inc. (Nasdaq: EYEN), a commercial-stage ophthalmic technology company commercializing Mydcombi™ (tropicamide+phenylephrine ophthalmic spray for mydriasis) and developing the Optejet® device for use both in connection with its own drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, today announced management will deliver a presentation at the H.C. Wainwright 25th Annual Global Investment Conference, which is taking place on September 11-13, 2023 at the Lotte New York Palace Hotel. H.C. Wainwright 25th Annual Global Investment ConferenceFormat: On-DemandAvailable: Beginning Monday, September 11, 2023 at 7:00am ETWebcast: https://journey.ct.events/view/002ac4ec-0d8d-4aa9-8c0f-c72b5bec025dThe...

ROCKAWAY, N.J., Sept. 07, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan Goldberger, will present at the H.C. Wainwright 25th Annual Global Investment Conference. H.C. Wainwright 25th Annual Global Investment Conference:Date: Monday, September 11, 2023Time: Recorded presentation available starting at 7:00 am ETEvent: Company Presentation For more information regarding the conference and to register, please visit the conference page here. About electroCore, Inc.electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management...

West Seneca, N.Y., Sept. 07, 2023 (GLOBE NEWSWIRE) — Worksport (Nasdaq: WKSP; WKSPW) is elated to announce that it has found a top-tier solar panel provider for its highly anticipated SOLIS Solar Tonneau Cover. This partner is renowned for their state-of-the-art solar panels and underlying technology. A supply partner will help set a new standard in renewable energy tech for vehicles and to provide the most durable and highest quality flexible solar panels. With this supply partner for SOLIS, the Company is demonstrating its unwavering commitment to pioneering sustainable technological solutions. The sample solar panels presented to Worksport and tested in Worksport’s SOLIS Solar Cover epitomize resilience and innovation. Adhering to rigorous environmental and structural standards, these panels incorporate high-quality components...

CARSON CITY, Nev., Sept. 07, 2023 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, is hosting today a virtual KOL event titled NE3107―Putting Data in Context, ahead of the upcoming Phase 3 results in Alzheimer’s Disease. The event will take place today at 2:30pm ET. To register, click here. The event will focus on BioVie’s lead product candidate, NE3107, currently in a potentially pivotal Phase 3 study in patients with mild to moderate Alzheimer’s disease with expected topline data readout in the fourth quarter of 2023. The company’s leadership team and Key Opinion Leader (KOL) Steven E. Arnold, MD (Harvard Medical School; Massachusetts General Hospital)...

NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) — BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative therapies to improve clinical outcomes for patients with high unmet medical needs, today announced that management will present and participate in the R.W. Baird’s 2023 Global Healthcare Conference, taking place on September 12 to 13, 2023 in New York City. The presentation will be accessible on BeyondSpring’s website on the Events & Presentations page following the conclusion of the conference. About BeyondSpringBeyondSpring (NASDAQ: BYSI) is a global clinical-stage biopharmaceutical company focused on developing innovative therapies to improve clinical outcomes for...

Thumzup Media CorporationThe Thumzup mobile appPaid content creators have grown more than 786% this year Los Angeles, CA, Sept. 07, 2023 (GLOBE NEWSWIRE) — Thumzup Media Corporation (“Thumzup” or the “Company”) (OTCQB: TZUP) is pleased to announce that it has surpassed 10,000 paid posts on its platform*. The news comes on the heels of Thumzup recently announcing its userbase has grown by more than 786 percent this year. The Thumzup mobile app, which is available for download in the App Store and Google Play, enables advertisers to garner user generated content from customers and fans, incentivizing them to become social media advocates for the brands they enjoy by paying them cash for approved posts. “Surpassing 10,000 paid posts is a significant achievement for the Thumzup platform and we believe...

Mike BruceChief Executive Officer of Brown & Brown EuropeDAYTONA BEACH, Fla., Sept. 07, 2023 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE: BRO) has announced the promotion of Mike Bruce to chief executive officer of Brown & Brown Europe. Mike was formerly the chief executive officer of Global Risk Partners (GRP), which was acquired by Brown & Brown in July 2022. In his new role, Mike will lead Brown & Brown’s overall European strategy. Commenting on the business rationale, Mike said his goal is to enable the European teams to build more connectivity and leverage the financial strength and scale of Brown & Brown with insurers, customers and potential acquisitions. Mike says, ”Our teammates will be able to derive value from our combined capabilities and deeper collaboration. ‘The Power of...

• Update on Phase 2a data for JNJ-0953 (CD388) for universal prevention of seasonal influenza from Janssen Pharmaceuticals, Inc. leadership following Election to Proceed notification • Detailed overview of potential role of Drug-Fc Conjugates (DFCs) in oncology; Cidara to present clinical development strategy for DFCs, focusing on CD73, chemokine receptors, and multispecific DFCs targeting solid tumors • Formal Q&A session with KOL’s to follow presentations SAN DIEGO, Sept. 07, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced it will host a virtual R&D Day on Thursday, September...

MIAMI, Sept. 07, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN NASDAQ: LGVNR) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (HLHS), Alzheimer’s disease and Aging-related Frailty, announced today an abstract highlighting long-term survival data from the Company’s ELPIS 1 trial of Lomecel-B™ for patients with hypoplastic left heart syndrome (HLHS) has been accepted for presentation as a poster at the upcoming meeting of the American Heart Association (AHA). The poster, titled Long-term Transplant-free Survival Is Improved in Hypoplastic Left Heart Syndrome with Cell-based Therapy (Sunjay Kaushal, et al.), will be presented at the Scientific Sessions of the American Heart...

Includes a state-of-the-art broadcast studio, dedicated IPO and Market Intelligence Centers, and a gallery space celebrating Nasdaq-listed companies CNBC’s “Fast Money” will broadcast its show from the new studio each weeknight at 5pm ET at MarketSite Coincides with the launch of Nasdaq’s new brand campaignNEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced the reopening of the second floor of its iconic MarketSite at 151 W. 42nd Street in Times Square. The new space includes a state-of-the-art broadcast and production studio that will be home to CNBC’s “Fast Money,” a dedicated IPO Center for first trade celebrations, and a new gallery space commemorating the historic moments and innovation of our listed companies, many of which are Nasdaq-100® companies. “Since its inception, the Nasdaq MarketSite...